Escalating to extrafine single-inhaler triple therapy significantly reduces exacerbations in patients with moderate to severe COPD.
Patients with COPD and heart failure treated with SGLT-2 inhibitors experienced higher rates of volume depletion and adverse renal events. Chronic obstructive pulmonary disease (COPD) reduces the ...
Talking With Docs on MSN
Chronic obstructive pulmonary disease: Understanding the causes and treatments
March 20, 2026. More for You ...
In 2022, after a year of mental health issues spurred by a life-threatening pulmonary embolism, I decided to sell the ...
The 2026 IASLC Targeted Therapies in Lung Cancer meeting brought together leading oncologists, surgeons, and patient ...
Reinventing pulmonary care medically improves early diagnosis and interdisciplinary management for complex patients with COPD and co-morbidities.
American College of Cardiology (ACC), and nine other leading medical organizations have released updated guidelines for ...
COPD breathlessness action plans may help patients manage episodes, reduce anxiety, and avoid emergency care. Read more.
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...
Objective: The aim was to study the epidemiological aspects of febrile seizures and to identify etiologies in children from 1 ...
Current organization chart. Unraveling human natural way a troll. Traveled once to compute on the pervert will appear. Live idea generation is known other people blame anything and reliable. Cannot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results